![Klaus Edvardsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Klaus Edvardsen
Directeur Technique/Scientifique/R&D chez
NYKODE THERAPEUTICS
Profil
Klaus Edvardsen currently works at Merck Ventures BV, as Senior Vice President and Nykode Therapeutics ASA, as Chief Research & Development Officer from 2022.
Dr. Edvardsen also formerly worked at AstraZeneca PLC, as SVP& Head-Global Medicines Development Oncology and CureVac NV, as Chief Development Officer from 2021 to 2022.
Dr. Edvardsen received his doctorate degree from the University of Copenhagen.
Postes actifs de Klaus Edvardsen
| Sociétés | Poste | Début |
|---|---|---|
| NYKODE THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/07/2022 |
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Anciens postes connus de Klaus Edvardsen
| Sociétés | Poste | Fin |
|---|---|---|
| CUREVAC | Corporate Officer/Principal | 30/06/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Formation de Klaus Edvardsen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements. | Finance |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
